XML 85 R36.htm IDEA: XBRL DOCUMENT v3.19.3
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense and Resulting Tax Benefits
Stock-based compensation expense and the resulting deferred tax benefits were as follows (in thousands):
 
Three Months Ended September 30,
 
2019
2018
Pre-tax stock-based compensation expense (a)
$
3,704

$
6,091

Deferred tax benefit
959

1,504

Total stock-based compensation expense, net of tax
$
2,745

$
4,587


(a)
Pre-tax stock based compensation expense attributable to discontinued operations of $0.1 million for the three months ended September 30, 2018 is not included in the above table.
Schedule of Information Related to Restricted Stock
The following table includes information related to restricted stock, performance share awards and stock options for the three months ended September 30, 2019:
 
Restricted Stock
 
Performance Share Awards
 
Stock Options

Number of Awards
Weighted Average Fair Value at Grant Date
 
Number of Awards
Weighted Average Fair Value at Grant Date
 
Number of Options
Weighted Average Exercise Price
Outstanding at June 30, 2019
589,550

$
37.06

 
1,439,815

$
36.38

 
2,798,673

$
30.22

Granted
276,406

$
36.61

 
697,870

$
36.23

 

$

Vested/exercised
(161,505
)
$
32.07

 
(493,759
)
$
31.58

 
(65,999
)
$
31.67

Forfeited
(12,071
)
$
39.71

 
(25,246
)
$
40.03

 
(9,500
)
$
32.62

Outstanding at September 30, 2019
692,380

$
38.00

 
1,618,680

$
37.73

 
2,723,174

$
30.18

 
 
 
 
 
 
 
 
 
Stock options outstanding and exercisable at September 30, 2019
 
 
 
 
 
 
2,572,310

$
30.04


Schedule of Information Related to Performance Share Awards
The following table includes information related to restricted stock, performance share awards and stock options for the three months ended September 30, 2019:
 
Restricted Stock
 
Performance Share Awards
 
Stock Options

Number of Awards
Weighted Average Fair Value at Grant Date
 
Number of Awards
Weighted Average Fair Value at Grant Date
 
Number of Options
Weighted Average Exercise Price
Outstanding at June 30, 2019
589,550

$
37.06

 
1,439,815

$
36.38

 
2,798,673

$
30.22

Granted
276,406

$
36.61

 
697,870

$
36.23

 

$

Vested/exercised
(161,505
)
$
32.07

 
(493,759
)
$
31.58

 
(65,999
)
$
31.67

Forfeited
(12,071
)
$
39.71

 
(25,246
)
$
40.03

 
(9,500
)
$
32.62

Outstanding at September 30, 2019
692,380

$
38.00

 
1,618,680

$
37.73

 
2,723,174

$
30.18

 
 
 
 
 
 
 
 
 
Stock options outstanding and exercisable at September 30, 2019
 
 
 
 
 
 
2,572,310

$
30.04


Schedule of Information Related to Stock Options
The following table includes information related to restricted stock, performance share awards and stock options for the three months ended September 30, 2019:
 
Restricted Stock
 
Performance Share Awards
 
Stock Options

Number of Awards
Weighted Average Fair Value at Grant Date
 
Number of Awards
Weighted Average Fair Value at Grant Date
 
Number of Options
Weighted Average Exercise Price
Outstanding at June 30, 2019
589,550

$
37.06

 
1,439,815

$
36.38

 
2,798,673

$
30.22

Granted
276,406

$
36.61

 
697,870

$
36.23

 

$

Vested/exercised
(161,505
)
$
32.07

 
(493,759
)
$
31.58

 
(65,999
)
$
31.67

Forfeited
(12,071
)
$
39.71

 
(25,246
)
$
40.03

 
(9,500
)
$
32.62

Outstanding at September 30, 2019
692,380

$
38.00

 
1,618,680

$
37.73

 
2,723,174

$
30.18

 
 
 
 
 
 
 
 
 
Stock options outstanding and exercisable at September 30, 2019
 
 
 
 
 
 
2,572,310

$
30.04


Schedule of Unrecognized Stock-Based Compensation Expense
Unrecognized stock-based compensation expense at September 30, 2019 was as follows (in thousands):
 
Unrecognized Stock-Based Compensation Expense
Weighted Average Amortization Period
Restricted stock
$
17,826

2.4 years
Performance share awards
39,619

2.3 years
Stock options
1,452

0.9 years
Total unrecognized stock-based compensation expense
$
58,897

2.2 years

Schedule of Aggregate Intrinsic Value of Stock Options
The aggregate intrinsic value of stock options at September 30, 2019 was as follows (in thousands):
 
Intrinsic Value of Stock Options
Outstanding and exercisable
$
2,513

Expected to vest
2

Total outstanding
$
2,515

 
 
Exercised during the three months ended September 30, 2019
$
394